Singapore’s 20 most traded stocks with style factors of high Return-on-Equity (ROE) and low Debt-to-Assets have declined in-line with benchmarks in early 2020, however outperformed over the past 5 years by 5% per year.
Majority of the STI Constituents are sticking to quarterly reporting. DBS and OCBC Bank are opting for abridged financial disclosures instead of the detailed quarterly earnings reports. Mapletree Commercial Trust, Mapletree Logistics Trust, SGX, Keppel Corp, DBS Bank and UOB – have announced that they will unveil results for the quarter ended 31 March 2020 over the next few weeks.
Soilbuild Business Space REIT, ParkwayLife REIT, Frasers Centrepoint Trust, Mapletree Industrial Trust, Mapletree North Asia Commercial Trust, and Lendlease Global Commercial REIT – have confirmed they will unveil results for the quarter ended 31 March 2020 over the next 3 weeks.
STI stocks that saw the biggest pick up in intra-day volatility in 1Q20 included CapitaLand Mall Trust, CapitaLand Commercial Trust, Genting Singapore, SATS & Ascendas REIT. The STI stocks that maintained the highest intra-day volatility in 1Q20 included Yangzijiang Shipbuilding, Mapletree Logistics Trust, Thai Beverage, SPH & Sembcorp Industries.
In the 2020 year to 3 April, Singapore Airlines, SIA Engineering, SATS and ST Engineering averaged declines of 38% bringing their average 10-year total returns to a marginal gain of 7%. This was in-line with the median performances of the 280 global aviation, aerospace and airport services stocks.
In March, 65 SGX primary-listed stocks bought back shares for a total consideration of S$502 million. This was the highest monthly consideration since S$544 million in consideration was reported for the month of August 2015. DBS, OCBC and UOB led the consideration tally, accounting for 88% of the total consideration.
Last week the Singapore Government increased its Fiscal Stimulus to S$55 billion, equivalent to 11% of Singapore’s GDP, while the United States Congress also passed a US$2.2 trillion Stimulus Package, similarly proportioned to its US$20 trillion GDP. STI stocks have been mixed in March (through to 27 March) with the STI declining 16%.
On 24-March, S-REITs lodged one of their five strongest sessions since their inception in 2002, with an 8% gain, after trading at 8 years lows on Monday. 3 S-REITs that were recipient to the highest net institutional inflow, proportionate to market value on 24 March, were Manulife US REIT, Mapletree Industrial Trust & Mapletree Logistics Trust. The trio averaged 16.2% price gains on 24 March
In the month of March (through to 20 Mar), 53 SGX primary-listed stocks bought back shares for a total consideration of S$448 million. This has brought the consideration for the month to date to the highest level since S$544 million in consideration for the month of August 2015.
In Singapore, hi-tech manufacturers, 2 REITs investing in Data Centres, a Business Trust investing in India IT parks, have maintained median 17% annualised total returns over the past 5 years, ranging from 10% for Valuetronics and Ascendas India Trust to 87% for AEM Holdings.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.